Such advancements in knowledge of the metabolic implications of Mustn1 can contribute to the broader understanding of metabolic physiology and pathophysiology, paving the way for innovations in the treatment of not only skeletal muscle diseases, but also metabolic diseases and enhancing our ability to manipulate such processes therapeutically. The gene discussed is MUSTN1; the disease is metabolic disease.